Atlas Trials

Grade III Meningioma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Grade III Meningioma

RecordFirmDate
Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study (NCT04278118)Emory University2020-02-18
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma (NCT02847559)Northwestern University2016-08-01
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 (NCT01082926)City of Hope Medical Center2010-05-01

Track Grade III Meningioma automatically

Every clearance here is in the API, with alerts when new ones post.